The company will closely work with the USFDA to address and respond to the observations in an expeditious manner
USFDA conducted an inspection at the Injectable Manufacturing site situated at Jarod, near Vadodara. The inspection was conducted from April 15 to April 23, 2024.
The inspection closed with 10 observations. The company will closely work with the USFDA to address and respond to the observations in an expeditious manner.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)
.jpg)
